Neta Ilan

10.0k total citations
156 papers, 8.4k citations indexed

About

Neta Ilan is a scholar working on Cell Biology, Molecular Biology and Hematology. According to data from OpenAlex, Neta Ilan has authored 156 papers receiving a total of 8.4k indexed citations (citations by other indexed papers that have themselves been cited), including 133 papers in Cell Biology, 131 papers in Molecular Biology and 19 papers in Hematology. Recurrent topics in Neta Ilan's work include Proteoglycans and glycosaminoglycans research (132 papers), Glycosylation and Glycoproteins Research (89 papers) and Fibroblast Growth Factor Research (61 papers). Neta Ilan is often cited by papers focused on Proteoglycans and glycosaminoglycans research (132 papers), Glycosylation and Glycoproteins Research (89 papers) and Fibroblast Growth Factor Research (61 papers). Neta Ilan collaborates with scholars based in Israel, United States and Sweden. Neta Ilan's co-authors include Israël Vlodavsky, Michael Elkin, Joseph A. Madri, Ralph D. Sanderson, Flonia Levy‐Adam, Anna Zetser, Itay Shafat, Inna Naroditsky, Svetlana Gingis‐Velitski and Victoria Cohen‐Kaplan and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nucleic Acids Research and Journal of Biological Chemistry.

In The Last Decade

Neta Ilan

154 papers receiving 8.3k citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author						Papers	Cites
Neta Ilan	6.0k	5.8k	1.1k	1.0k	959	156	8.4k
Ralph D. Sanderson	6.0k 1.0×	7.2k 1.2×	2.1k 1.9×	1.8k 1.7×	2.1k 2.2×	128	11.1k
Gregory David	2.4k 0.4×	4.5k 0.8×	751 0.7×	799 0.8×	711 0.7×	107	7.0k
Åke Wasteson	2.2k 0.4×	4.5k 0.8×	934 0.8×	1.0k 1.0×	765 0.8×	88	7.6k
Eyal Zcharia	2.8k 0.5×	2.5k 0.4×	475 0.4×	432 0.4×	591 0.6×	54	4.0k
Craig Freeman	2.1k 0.4×	2.2k 0.4×	361 0.3×	347 0.3×	398 0.4×	73	3.8k
Yuen Shing	1.4k 0.2×	7.1k 1.2×	3.3k 2.9×	1.9k 1.8×	651 0.7×	57	10.4k
Edward B. Leof	899 0.2×	4.1k 0.7×	749 0.7×	1.5k 1.4×	496 0.5×	106	7.3k
Kaoru Miyazaki	1.4k 0.2×	3.5k 0.6×	3.2k 2.9×	2.4k 2.3×	1.3k 1.3×	181	8.3k
Thomas Maciag	1.9k 0.3×	5.3k 0.9×	1.0k 0.9×	741 0.7×	324 0.3×	63	7.3k
Judith A. Abraham	1.6k 0.3×	7.5k 1.3×	1.7k 1.6×	1.8k 1.8×	462 0.5×	66	11.0k

Countries citing papers authored by Neta Ilan

Since Specialization

Citations

This map shows the geographic impact of Neta Ilan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Neta Ilan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Neta Ilan more than expected).

Fields of papers citing papers by Neta Ilan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Neta Ilan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Neta Ilan. The network helps show where Neta Ilan may publish in the future.

Co-authorship network of co-authors of Neta Ilan

This figure shows the co-authorship network connecting the top 25 collaborators of Neta Ilan. A scholar is included among the top collaborators of Neta Ilan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Neta Ilan. Neta Ilan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Barash, Uri, Inna Naroditsky, Marina Weissmann, et al.. (2024). Tumor- and host-derived heparanase-2 (Hpa2) attenuates tumorigenicity: role of Hpa2 in macrophage polarization and BRD7 nuclear localization. Cell Death and Disease. 15(12). 894–894. 1 indexed citations

Naroditsky, Inna, Sari Feld, Ilanit Boyango, et al.. (2024). Nuclear localization of heparanase 2 (Hpa2) attenuates breast carcinoma growth and metastasis. Cell Death and Disease. 15(3). 232–232. 4 indexed citations

Vlodavsky, Israël, et al.. (2024). Impact of heparanase‐2 (Hpa2) on cancer and inflammation: Advances and paradigms. The FASEB Journal. 38(10). e23670–e23670. 4 indexed citations

Vlodavsky, Israël, et al.. (2023). Heparanase—A single protein with multiple enzymatic and nonenzymatic functions. PubMed. 1(3). e6–e6. 21 indexed citations

Barash, Uri, et al.. (2023). Heparanase 2 (Hpa2)- a new player essential for pancreatic acinar cell differentiation. Cell Death and Disease. 14(7). 465–465. 9 indexed citations

Singh, Preeti, et al.. (2021). Heparanase 2 (Hpa2) attenuates the growth of pancreatic carcinoma. Matrix Biology. 98. 21–31. 15 indexed citations

Gutter-Kapon, Lilach, Neta Ilan, Tahira Batool, et al.. (2020). Significance of host heparanase in promoting tumor growth and metastasis. Matrix Biology. 93. 25–42. 24 indexed citations

Barash, Uri, Pei Liu, Euvgeni Vlodavsky, et al.. (2019). Heparanase promotes glioma progression via enhancing CD24 expression. International Journal of Cancer. 145(6). 1596–1608. 34 indexed citations

Bhattacharya, Udayan, Lilach Gutter-Kapon, Ilanit Boyango, et al.. (2019). Heparanase and Chemotherapy Synergize to Drive Macrophage Activation and Enhance Tumor Growth. Cancer Research. 80(1). 57–68. 38 indexed citations

10.

Weissmann, Marina, Gil Arvatz, Netanel A. Horowitz, et al.. (2016). Heparanase-neutralizing antibodies attenuate lymphoma tumor growth and metastasis. Proceedings of the National Academy of Sciences. 113(3). 704–709. 89 indexed citations

11.

Kundu, Soumi, Anqi Xiong, Grzegorz Wicher, et al.. (2016). Heparanase Promotes Glioma Progression and Is Inversely Correlated with Patient Survival. Molecular Cancer Research. 14(12). 1243–1253. 52 indexed citations

12.

Feld, Sari, Ilana Doweck, Gera Neufeld, et al.. (2016). Heparanase 2 Attenuates Head and Neck Tumor Vascularity and Growth. Cancer Research. 76(9). 2791–2801. 35 indexed citations

13.

Shteingauz, Anna, Ilanit Boyango, Inna Naroditsky, et al.. (2015). Heparanase Enhances Tumor Growth and Chemoresistance by Promoting Autophagy. Cancer Research. 75(18). 3946–3957. 130 indexed citations

14.

Mumblat, Yelena, Ofra Kessler, Neta Ilan, & Gera Neufeld. (2015). Full-Length Semaphorin-3C Is an Inhibitor of Tumor Lymphangiogenesis and Metastasis. Cancer Research. 75(11). 2177–2186. 60 indexed citations

15.

Boyango, Ilanit, Uri Barash, Inna Naroditsky, et al.. (2014). Heparanase Cooperates with Ras to Drive Breast and Skin Tumorigenesis. Cancer Research. 74(16). 4504–4514. 61 indexed citations

16.

Fux, Liat, Victoria Cohen‐Kaplan, Svetlana Gingis‐Velitski, et al.. (2009). Structure-Function Approach Identifies a COOH-Terminal Domain That Mediates Heparanase Signaling. Cancer Research. 69(5). 1758–1767. 84 indexed citations

17.

Nasser, Nicola J., Aaron Avivi, Itay Shafat, et al.. (2009). Alternatively spliced Spalax heparanase inhibits extracellular matrix degradation, tumor growth, and metastasis. Proceedings of the National Academy of Sciences. 106(7). 2253–2258. 46 indexed citations

18.

Cohen‐Kaplan, Victoria, Ilana Doweck, Inna Naroditsky, Israël Vlodavsky, & Neta Ilan. (2008). Heparanase Augments Epidermal Growth Factor Receptor Phosphorylation: Correlation with Head and Neck Tumor Progression. Cancer Research. 68(24). 10077–10085. 82 indexed citations

19.

Zetser, Anna, Yulia Bashenko, Evgeny Edovitsky, et al.. (2006). Heparanase Induces Vascular Endothelial Growth Factor Expression: Correlation with p38 Phosphorylation Levels and Src Activation. Cancer Research. 66(3). 1455–1463. 208 indexed citations

20.

Zetser, Anna, Yulia Bashenko, Hua‐Quan Miao, Israël Vlodavsky, & Neta Ilan. (2003). Heparanase affects adhesive and tumorigenic potential of human glioma cells.. PubMed. 63(22). 7733–41. 136 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact